SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

UBS Maintains Buy on Tandem Diabetes Care, Raises Price Target to $106

UBS maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Buy and raises the price target from $98 to $106.

Benzinga · -
UBS maintains Tandem Diabetes Care (NASDAQ: TNDM) with a Buy and raises the price target from $98 to $106.